TRIM33 and dermatomyositis: More specifically, we have previously shown that adult DM patients with cancer have a significantly higher frequency and serological level of anti-TIF1γ-IgG2 isotype [4], which raises the question of whether there is also an association between anti-TIF1γ-IgG2 isotype and cancer in JDM.